Skip to main content
SpringerLink
Log in

Low Molecular Weight Heparin in Immunological Recurrent Abortion—The Incredible Cure

  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

The most compelling association between pregnancy loss and autoimmune phenomena has been with the presence of antiphospholipid antibodies (APA)—lupus anticoagulant and anticardiolipin antibody. The ‘antiphospholipid antibody syndrome’ has been described in women with a history of recurrent pregnancy loss or thrombosis with positive APA or lupus anticoagulant on two occasions. Although several treatments have been advocated, heparin and aspirin treatment is emerging as the treatment of choice for the APA syndrome associated with recurrent pregnancy loss. The rationale for prescribing aspirin in cases of recurrent reproductive failure associated with APA seropositivity is that aspirin may counter APA-mediated hypercoagulability in the choriodecidual space, a situation which if left unaddressed would traumatize the trophoblast and compromise feto-maternal exchange. Heparin on the other hand, through preventing APA from interfering with syncytialization of the early cytotrophoblast and by countering APA interference with phospholipid-decidual reactions that are vital to early implantation, might potentially promote both early implantation and subsequent placentation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Edmonds DK, Lindsay KI, Miller JF: Early embryonic mortality in women. Fertil Steril 1982;38:447–453

    PubMed  Google Scholar 

  2. Alberman E: The epidemiology of repeated abortion. In Early Pregnancy Loss: Mechanisms and Treatment, F Sharp, RW Beard (eds), New York, Springer, 1988, pp 9–17

    Google Scholar 

  3. Stray-Pederson B, Stray-Pederson S: Etiological factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984;148:140–146

    PubMed  Google Scholar 

  4. Hill JA: Immunological mechanisms of pregnancy maintenance and failure: A critique of theories and therapy. Am J Reprod Immunol 1990;22:1–12

    PubMed  Google Scholar 

  5. Mueh JR, Herbst KD, Rapaport SI: Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980;92:156–159

    PubMed  Google Scholar 

  6. Gastineau DA, Keizmer FS, Nichols WL: Lupus anticoagulant: An analysis of the clinical and Laboratory features of 219 cases. Am J Hematol 1985;19:265–275

    PubMed  Google Scholar 

  7. Harris EN, Chan JKH, Asherson RA: Thrombosis, recurrent fetal loss and thrombocytopenia: Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986;146:2153–2159

    PubMed  Google Scholar 

  8. Cowchock FS: The role of antiphospholipid antibodies in obstetric medicine. In Current Obstetric Medicine, RV Lee (ed), Mosby-Yearbook, St Louis, MO, pp 229–247

  9. Lockwood C, Reece LA, Roniero LT, Hobbins JC: Antiphospholipid antibody and pregnancy wastage. Lancet 1986;ii: 742–743

    Google Scholar 

  10. Gleicher N, Pratt D, Dudkiewicz A: What do we really know about autoantibody abnormalities and reproductive failure: A critical review. Autoimmunity 1993;16:115–140

    PubMed  Google Scholar 

  11. Rai RS, Regan L, Clifford K, Pickering W, Dave M, Mackie I: Antiphospholipid antibodies and β-2 glycoprotein-I in 500 women with recurrent miscarriage: Results of a comprehensive screening approach. Hum Reprod 1995;10:101–105

    Google Scholar 

  12. Balasch J, Creus M, Fábrogues F: Antiphospholipid antibodies and human reproductive failure. Hum Reprod 1996;11:2310–2315

    PubMed  Google Scholar 

  13. Hatasaka HH, Branch DW, Kutteh W, Scott JR: Autoantibody screening for infertility: Explaining the unexplained? J Reprod Immunol 1997;34:137–153

    PubMed  Google Scholar 

  14. Balasch J, Font J: Antiphospholipid antibody testing in patients with pregnancy loss. Lupus 1994;3:429–431

    PubMed  Google Scholar 

  15. Balasch J: Immunological factors in pregnancy wastage: Truth or fiction. In Progress in Reproductive Medicine, Vol 2, R Asch, JWW Studd (eds), London, Parthenon, 1995, pp 117–138

    Google Scholar 

  16. Rai RS, Cohen H, Regan L: Non-pregnant women with a history of recurrent miscarriage are in a pro-thrombotic state. Hum Reprod 1996;11:27–29

    PubMed  Google Scholar 

  17. Panton IA, Kilpatrick DC: Anti-cardiolipin antibodies in sexual partners of recurrent aborters. Hum Reprod 1997;12:464–467

    PubMed  Google Scholar 

  18. El-Roeiy A, Dmowski WP, Gleicher N: Danazol but not gonadotrophin-releasing hormone agonists suppress autoantibodies in endometriosis. Fertil Steril 1988;50:864–871

    PubMed  Google Scholar 

  19. E1-Roeiy A, Gleicher N: Definition of normal autoantibody levels in an apparently healthy population. Obstet Gynecol 1988;77:596–602

    Google Scholar 

  20. Ober C, Kamson T, Harcowe L: Autoantibodies and pregnancy history in a healthy population. Am J Obstet Gynecol 1993;169:143–147

    PubMed  Google Scholar 

  21. Moulias R, Proust J, Wanga A: Age related increase in autoantibodies. Lancet 1984;i:178–1129

    Google Scholar 

  22. Shoenfeld Y, Segol G, Segol D: Detection of antibodies to total bistones and their subfraction in systemic lupus erythematosus patients and their asymptomatic relatives. Arthritis Rheumatica 1987;30:169–175

    Google Scholar 

  23. Gleicher N, Luih C, Dudkiewicz A: Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success. Am J Obstet Gynecol 1994;170:1145–1149

    PubMed  Google Scholar 

  24. El-Roeiy A, Gleicher N, Fribert T: Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization. Obstet Gynecol 1987;70:163–170

    PubMed  Google Scholar 

  25. Gleicher N, El-Roeiy A, Carfino E, Fnberg J: Reproductive failure because of autoantibodies: Unexplained infertility and pregnancy wastage. Am J Obstet. Gynecol 1989;160:1376–1380

    PubMed  Google Scholar 

  26. Geva F, Yaron V, Lessing JB: Circulatory autoimmune antibodies may be responsible for implantation failure in in-vitro fertilization. Fertil Steril 1994;62:802–806

    PubMed  Google Scholar 

  27. El-Roeiy A, Myers SA, Gleicher N: The relationship between autoantibodies and intrauterine growth retardation in hypertensive disorders of pregnancy. Am J Obstet Gynecol 1991;164:1253–1261

    PubMed  Google Scholar 

  28. Kajino T: Polyclonal activation of 1gM antibodies to phospholipids in patients with idiopathic growth retardation. Am J Reprod. Immunol 1991;28:231–234

    Google Scholar 

  29. Polzin WJ, Kopelman JN, Robinson RD: The association of antiphospholipid antibodies with pregnancies complicated by fetal growth retardation. Obstet Gynecol 1991;78:1108–1111

    PubMed  Google Scholar 

  30. Out HJ, Bruinse HW, Christiaens GCML. A prospective, controlled multicenter study on obstetric risk of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992;167:26–32

    PubMed  Google Scholar 

  31. Yasuda M, Takakuwa K, Tokunaga A, Tanaka K: Prospective studies of th association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995;86:555–559

    PubMed  Google Scholar 

  32. Lockshin RD, Druzin ML, Goei S: Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985;313:152–156

    PubMed  Google Scholar 

  33. Tan SL, Doyle P, Campbell S: Obstetric outcome of in vitro fertilization pregnancies compared with normally conceived pregnancies. Am J Obstet Gynecol 1992;167:773–784

    Google Scholar 

  34. Nurat P, Olivennes F, de Muzon J: Task force report on the outcome of pregnancies and children conceived by in vitro fertilization (France: 1987 to 1989). Fertil Steril 1994;61:324–330

    PubMed  Google Scholar 

  35. Olivennes F, Kadhel P, Rufat P: Perinatal outcome of twin pregnancies obtained after in vitro fertilization: Comparison with twin pregnancies obtained spontaneously after ovarian stimulation. Fertil Steril 1996;66:105–109

    PubMed  Google Scholar 

  36. Harris EN: Special report. The second international anti-cardiolipin standardization workshop/the Kingston Anti-phospholipid Antibody Study (KAPS) Group. Am J Clin Pathol 1990;94:476–84

    PubMed  Google Scholar 

  37. Lockshin MD: Antiphospholipid antibody syndrome. JAMA 1992;268:451–1453

    PubMed  Google Scholar 

  38. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L: Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992;166:1318–23

    PubMed  Google Scholar 

  39. Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low dose aspirin is superior to low dose aspirin. Am J Obstet Gynecol 1996;174:1584–1589

    PubMed  Google Scholar 

  40. Raziel A, HermanA, BukovskyI: Intravenous immunoglobulin treatment of pregnant patients with unexplained recurrent abortions. Hum Reprod 1996;11:711–715

    PubMed  Google Scholar 

  41. Bronson R: Editorial: Immunology and reproductive medicine. Hum Reprod 1995;10:755–757

    PubMed  Google Scholar 

  42. Branch DW, Silver RM, Blackwell LL: Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992;80:614–620

    PubMed  Google Scholar 

  43. Roubey RA: Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other phospholipid antibodies. Blood 1994;89:2854–2867

    Google Scholar 

  44. Gleicher N, Liu H, Dudkiewicz A: Autoantibody profiles and immunoglobulin levels as predictors of IVF success. Am J Obstet Gynecol 1994;170:1145–1149

    PubMed  Google Scholar 

  45. Birdsall MA, Lockwood GM, Ledger WL: Antiphospholipid antibodies in women having in-vitro fertilization. Hum Reprod 1996;11:1185–1189

    PubMed  Google Scholar 

  46. Sessions A, Horowitz AF: Differentiation-related difference in the plasma membrane phospholipid asymmetry of myogenic and firbrogenic cells. Biochim Biophys Acta 1982;728:103–111

    Google Scholar 

  47. Rote NS, Walter A, Lyden TW: Antiphospholipid antibodies–lobsters or red herrings? Am J Reprod Immunol 1992;28:31–7

    PubMed  Google Scholar 

  48. Sher G, Feinman M, Zouves C: High fecundity rates following in-vitro fertilization and embryo transfer in anti-phospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod 1994;9:2278–2283

    PubMed  Google Scholar 

  49. Kowalik A, Vichnin M, Branch W, Berkeley A: Mid-follicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with IVF outcome. American Society of Reproductive Medicine Meeting, November 1996, Boston, MA, USA. Abstract P-130

  50. Ermel LD, Marshbum PB, Kutteh WH: Interaction of heparin with antiphospholipid antibodies (APA) from serum of women with recurrent pregnancy loss (RPL). Am J Reprod Immunol 1995;33:14–20

    PubMed  Google Scholar 

  51. Patrono C: Aspirin as an antiplatelet drug. N Eng J Med 1994;330:1287–1294

    Google Scholar 

  52. Hauth JL: Low-dose aspirin: Lack of association with an increase in abruptio placentae or perinatal mortality. Obstet Gynecol 1995;85:1055–1058

    PubMed  Google Scholar 

  53. Malathy PV, Cheng HC, Dey SE: Production of leukotrienes and prostaglandins in the rat uterus during preimplantation period. Prostaglandins 1986;32:605–614

    PubMed  Google Scholar 

  54. Hoffman LH, Davenport GR, Brash AR: Endometrial prostaglandins and phospholipase activity related to implantation in rabbits: Effects of dexamethasone. Biol Reprod 1984;38:544–555

    Google Scholar 

  55. Johnston JM, Bleasdale JE, Hoffman DR: Functions of PAF in reproduction and development: involvement of PAF in fetal lung maturation and parturition. In Platelet-Activating Factor and Related Lipid Mediators, F Synyer (ed), New York, Plenum, 1987, p 375

    Google Scholar 

  56. O'Neill C: Embryo-derived platelet activating factor: A preimplantation embryo mediator of maternal recognition of pregnancy. Domest Anim Endocrinol 1987;4:69–85

    PubMed  Google Scholar 

  57. O'Neill C, Gidley-Baird AA, Pike JL, Porter RN, Sinosich MJ, Saunders DM: Maternal blood platelet physiology and luteal phase endocrinology as a means of monitoring pre and postimplantation embryo viability following in vitro fertilization. J In Vitro Fertil Embryo Transfer 1985;2:87–93

    Google Scholar 

  58. Holmes PV, Sjogren A, Hamberger L: Prostaglandin-E2 released by preimplantation human conceptuses. J Reprod Immunol 1989;17:79–86

    Google Scholar 

  59. van der Welden RMF, Helmerhorst FM, Keirse MJNC: Influence of prostaglandins and platelet activating factor on implantation. Hum Reprod 1991;6:436–442

    PubMed  Google Scholar 

  60. Sessions A, Horowitz AF: Myoblast aminophospholipid asymmetry differs from that of fibroblasts. FEBS 1981;34:75–78

    Google Scholar 

  61. Rauch J, Janoff AS: Phospholipid in the hexagonal 11 phase is immunogenic: Evidence for immunorecognition of nonbilayer lipid phases in vivo. Proc Nazi Acad Sci USA 1990;87:4112–4114

    Google Scholar 

  62. Asch RH: High pregnancy rates after oocyte and embryo donation. Hum Reprod 1993;7:734

    Google Scholar 

  63. Fisch B, Rikover Y, Shohat L, Zurgil N, Tadir Y, Ovadia J, Wik I, Yron I: The relationship between in vitro fertilization and naturally occurring antibodies: Evidence for increased production of antiphospholipid antibodies. Fertil Steril 1991;56(4):718–724

    PubMed  Google Scholar 

  64. Schwartz M, Jewelewicz R: The use of gonadotrophins for induction of ovulation. Fertil Steril 1991;35:3

    Google Scholar 

  65. Scialli AR: The reproductive toxicity of ovulation induction. Fertil Steril 1986;45:315

    PubMed  Google Scholar 

  66. McIntyre JA, Taylor CG, Torry DS, Wagenknecht DR, Wilson J, Faulk WP: Heparin and pregnancy in women with a history of repeated miscarriages. Haemostasis 1993;23(Suppl 1):202–211

    PubMed  Google Scholar 

  67. Harris EN, Gharavi AE, Hughes GRV: Antiphospholipid antibodies. Clin Rheum Dis 1985;11:591–609

    PubMed  Google Scholar 

  68. Matzner W, Chong F, Xu HF, Chung W: Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions. J Reprod Med 1994;39:27–30

    PubMed  Google Scholar 

  69. Jewolf F, Carreras LO, Moennan P: Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982;142, 829–834

    PubMed  Google Scholar 

  70. Out HJ, Kooijman CD, Bruinse HW, Derksen RH: Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991;41:179–186

    PubMed  Google Scholar 

  71. Lyden TW, Vogt E, Ng AK: Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. J. Reprod Immunol 1992;22:1–14

    PubMed  Google Scholar 

  72. Katsuragawa H, Kanzaki H, Inoue T: Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997;56:50–58

    PubMed  Google Scholar 

  73. Tartakovsky B, Bermas BL, Sthoeger Z: Defective maternal—fetal interaction in a murine autoimmune model. Hum Reprod 1996;11:2408–2411

    PubMed  Google Scholar 

  74. Kowalik A, Viehnin M, Li HC, Branch W, Berkeley A: Mid-follicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with in vitro fertilization outcome. Fertil Steril 1997;68:298–304

    PubMed  Google Scholar 

  75. Cowchock S, Reece EA: For the Organizing Group of the Antiphospholipid Antibody Treatment Trial. Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Am J Obstet Gynecol 1997;176:1099–1100

    PubMed  Google Scholar 

  76. Clark DA: Current concepts of immunoregulation of implantation. In Implantation: Biological and Clinical Aspects, M Chapman, G Grudzinskas, T Chard (eds), London, Springer, 1989, pp 163–175

    Google Scholar 

  77. Birkenfeld A, Mukaida T, Minichiello L: Incidence of autoimmune antibodies in failed embryo transfer cycles. Am J Reprod Immunol 1994;31:65–68

    PubMed  Google Scholar 

  78. Geva E, Amit A, Lemer-Geva L: Autoimmune disorders: Another possible cause for in-vitro fertilization and embryo transfer failure. Hum Reprod 1995;10:2560–2563

    PubMed  Google Scholar 

  79. Kaider B, Price DL, Rouses RG, Coulam CR: Antiphospholipid antibody prevalence in patients in an IVF program. J Reprod Immunol 1996;35:388–393

    Google Scholar 

  80. Rai R, Regan L: Antiphospholipid antibodies in women undergoing in-vitro fertilization. Hum Reprod 1997;12:197–198

    PubMed  Google Scholar 

  81. Di Simone N, Caliandro D, Castellani R, Freazzani G, Carolis S, Caruso A. Low molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod 1999;14:489–495

    PubMed  Google Scholar 

  82. Di Simone N, Ferrazzani S, Castellani R: Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera. Hum Reprod 1997;12:2061–2065

    PubMed  Google Scholar 

  83. Rand JH, Wu XX, Andree HAM: Pregnancy loss in the antiphospholipid antibody syndrome: A possible thrombogenic mechanism. N Engl J Med 1997;337:154–160

    Article  PubMed  Google Scholar 

  84. Mcintyre JA, Wagenknecht DR: Interaction of heparin with beta2-glycoprotein I and antiphospholipid antibodies in vitro. Thromb Res 1992;68:495–500

    PubMed  Google Scholar 

  85. Kutteh WH, Ermel LD: A clinical trial for the treatment of aPL associated RPL with lower dose heparin and aspirin. Am J Reprod Immunol 1996;35:402–407

    PubMed  Google Scholar 

  86. Dawes J, Bara L, Billaud E. Relationship between biological activity and concentration of a low molecular-weight heparin (PK 10169) and unfractionated heparin after intravenous and subcutaneous administration. Haemostasis 1986;16:116–122

    PubMed  Google Scholar 

  87. Dulitzki M, Pauzner R, Langevitz P: Low molecular weight heparin during pregnancy and delivery: Preliminary experience with 41 pregnancies. Obstet Gynecol 1996;87:380–383

    PubMed  Google Scholar 

  88. Ginsberg JS, Hirsch J: Use of antithrombotic agents during pregnancy. Chest 1995;108:305S-311S

    PubMed  Google Scholar 

  89. Bara L, Billaud E, Garamond G, Kher H: Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration. Thromb Res 1985;39:631–636

    PubMed  Google Scholar 

  90. Bara L, Samana M: Pharmacokinetics of low molecular weight heparins. Acta Chir Scand Suppl 1988;543:65–72

    PubMed  Google Scholar 

  91. Monreal M, Lafoz E, Olive A: Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (fragmin) in patients with venous thromboembolism and contraindications to Coumarin. Thromb Hemost 1994;71:7–11

    Google Scholar 

  92. Shefras J, Farquarson RG: Bone density studies in pregnant women receiving heparin. Eur J Obstet Gynecol Reprod Biol 1996;65:171–174

    PubMed  Google Scholar 

  93. Forestier F, Daffos F, Rainaut M, Toulemonde F: Low molecular weight heparin (Cy216) does not cross the placenta during the third trimester of pregnancy. Thromb Hemost 1987;57:234–239

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bombay Hospital & Medical Research Center, New Marine Lines, Mumbai, India

    Gautam N. Allahbadia

  2. Department of Obstetrics & Gynecology, LTMMC & LTMGH, Sion, Mumbai, India

    Swati G. Allahbadia

Authors
  1. Gautam N. Allahbadia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Swati G. Allahbadia
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allahbadia, G.N., Allahbadia, S.G. Low Molecular Weight Heparin in Immunological Recurrent Abortion—The Incredible Cure. J Assist Reprod Genet 20, 82–90 (2003). https://doi.org/10.1023/A:1021792125123

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021792125123

Search

Navigation